0000950170-25-025771.txt : 20250224 0000950170-25-025771.hdr.sgml : 20250224 20250224170316 ACCESSION NUMBER: 0000950170-25-025771 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250220 FILED AS OF DATE: 20250224 DATE AS OF CHANGE: 20250224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PYSZCZYMUKA GREG CENTRAL INDEX KEY: 0001952920 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36075 FILM NUMBER: 25658052 MAIL ADDRESS: STREET 1: C/O AYTU BIOPHARMA, INC. STREET 2: 373 INVERNESS PARKWAY, SUITE 206 CITY: ENGLEWOOD STATE: CO ZIP: 80112 FORMER NAME: FORMER CONFORMED NAME: PYSZCAYMUKA GREG DATE OF NAME CHANGE: 20221031 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evoke Pharma Inc CENTRAL INDEX KEY: 0001403708 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 208447886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 STEVENS AVENUE STREET 2: SUITE 230 CITY: SOLANA BEACH STATE: CA ZIP: 92075 BUSINESS PHONE: 858-345-1494 MAIL ADDRESS: STREET 1: 420 STEVENS AVENUE STREET 2: SUITE 230 CITY: SOLANA BEACH STATE: CA ZIP: 92075 4 1 ownership.xml 4 X0508 4 2025-02-20 0001403708 Evoke Pharma Inc EVOK 0001952920 PYSZCZYMUKA GREG C/O EVOKE PHARMA, INC. 420 STEVENS AVENUE, SUITE 230 SOLANA BEACH CA 92075 true false false false false Stock Option (Right to Buy) 5.26 2025-02-20 4 A false 5833 0 A 2035-02-19 Common Stock 5833 5833 D 1/3rd of the total number of shares of common stock subject to the option shall vest following each one-year period after February 20, 2025, the date of grant, subject to the Reporting Person's continuous service to the Issuer through each vesting date, so that the option shall be fully vested on the third anniversary of the date of grant. /s/ Matthew J. D'Onofrio, Attorney-in-fact for Greg Pyszczymuka 2025-02-24